Журнал клеточной и молекулярной фармакологии

Открытый доступ

Наша группа организует более 3000 глобальных конференций Ежегодные мероприятия в США, Европе и США. Азия при поддержке еще 1000 научных обществ и публикует более 700 Открытого доступа Журналы, в которых представлены более 50 000 выдающихся деятелей, авторитетных учёных, входящих в редколлегии.

 

Журналы открытого доступа набирают больше читателей и цитируемости
700 журналов и 15 000 000 читателей Каждый журнал получает более 25 000 читателей

Абстрактный

The International Society for Immunopharmacology's Invitation to Join

Gregor Mendel* and Dmitri Mendeleev

The field of immunopharmacology is rapidly evolving, with significant advancements in understanding the complex interactions between drugs and the immune system. The International Society for Immunopharmacology (ISI) has emerged as a leading global platform for scientists and researchers in this field, fostering collaboration, knowledge sharing, and the advancement of immunopharmacology research. This dissertation explores the invitation to join the ISI and its potential benefits for researchers and institutions, as well as the contributions of the society to the field of immunopharmacology. It delves into the resources, networking opportunities, conferences, and scientific publications provided by the ISI, highlighting the potential impact on individual researchers, institutions, and the field as a whole. The dissertation also examines the significance of joining the ISI in terms of global research collaborations, interdisciplinary approaches, and the dissemination of research findings. Through a comprehensive analysis of the invitation to join the ISI, this dissertation aims to provide insights into the advantages and opportunities associated with becoming a part of this esteemed international society.